Tykerb 250mg tablet – Blueberrypharma
Tykerb 250mg tablets are categorized as anti-neoplastic agent, which is orally active drug used for treating breast cancer.
Tykerb tablets are comes under biological category which is targeted chemotherapy.
Tykerb tablets are classified as;
1. Tyrosine kinase prohibitor
2. Stop the HER2/neu & epidermal growth factor receptor activity
3. Targeted therapy
4. Signal transduction prohibitor
PRODUCT DETAILS
DOSAGE
In HER2 positive advanced breast cancer:
The recommended dose of Tykerb is 1250mg should be administered orally as a single dose on day 1 to 21repeatedly combined with Capecitabine 2000mg/m2/day (should be taken orally in 2 doses relatively 12 hours apart) on day 1 to 14 in continuous 21 day cycle.
Totally 5 tablets of Tykerb should be taken at a time as whole.
In hormone receptor positive HER 2 positive advance breast cancer:
The prescribed dose is 1500mg should be administered orally as a single dose by combining with letrozole.
The prescribed dose of letrozole is 2.5mg as a once a day.
In these total 6 tablets of Tykerb should be administered as such.
SIDE EFFECTS
• Diarrhea
• Nausea
• Vomiting
• Stomatitis
• Back pain
• Dyspnea
• Insomnia
• Elevation of hemoglobulin, platelets, neutrophils
• Increase in AST & ALT, bilirubin
• Alopecia
• Pruritus
• Nail disorders
• Asthenia
• Headache
• Epistaxis
• Reduction of left ventricular ejection fraction
• Liver toxicity
• Interstitial lung disease
• Anaphylactic reactions
• Stevens Johnson syndrome
• Ventricular arrhythmias
• QT prolongation
CONTACT DETAILS
ADDRESS:
NEW NO. 3, Old No. 19, Cauvery Nagar 2nd Street, Kodungaiyur, chennai – 600 118.
PHONE:
+91-97890 77748
MAIL:
info@blueberrypharma.com
Comments
Post a Comment